Sign In
Buy PTGX
$95.41
+2.18 (+2.34%)
At Close: Jun 03, 2026
Protagonist Therapeutics Reports Granting of Inducement Award
06:27pm, Friday, 30'th Oct 2020
NEWARK, Calif., Oct. 30, 2020 /PRNewswire/ -- Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today reported that on October 31, 2020, it issued an inducement award to Nora Boyer, the Company's recently
